Application | Comment | Organism |
---|---|---|
medicine | kallikrein improves cardiac function and reduces infarct size in kininogen-deficient rats, icatibant and N-alpha-nitro-L-arginine-methyl-ester block kallikrein's cardioprotective effects | Rattus norvegicus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
Aprotinin | tissue kallikrein is inactivated by incubation with 5fold molar excess of aprotinin at 37°C for 1 h | Rattus norvegicus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | - |
- |
- |
Purification (Comment) | Organism |
---|---|
- |
Rattus norvegicus |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
cardiomyocyte | - |
Rattus norvegicus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
D-Val-Leu-Arg-4-nitroanilide + H2O | also known as S2266, a chromogenic substrate for tissue kallikrein | Rattus norvegicus | D-Val-Leu-Arg + 4-nitroaniline | - |
? | |
kinin B2 receptor + H2O | tissue kallikrein directly activates kinin B2 receptor in the absence of kininogen | Rattus norvegicus | ? | - |
? |